Universal-Beteiligungs- und Servicegesellschaft’s Arbutus Biopharma ABUS Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$189K	Buy	+39,474	New	+$173K	﹤0.01%	2037

Other funds holding ABUS

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM

Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's ABUS Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft opened a new position in Arbutus Biopharma (ABUS) in Q2 2026: 39,474 shares worth $189K. The stake represents ﹤0.01% of the portfolio and ranks #2037 among its holdings.

177 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft held 39,474 shares of Arbutus Biopharma worth $189K as of Q2 2026.
Arbutus Biopharma was a new Universal-Beteiligungs- und Servicegesellschaft position in Q2 2026.
Arbutus Biopharma made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #2037 holding.
177 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.